Retardation of Aβ fibril formation by phospholipid vesicles depends on membrane phase behavior

Biophysical Journal

Volumn 98, Issue 10, 2010, Pages 2206-2214

  Hellstrand, Erik ^a   Sparr, Emma ^a   Linse, Sara ^b  

^a Department of Biophysical Chemistry ^*  (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI;

AMYLOID; AMYLOID BETA PROTEIN; LIPID; MEMBRANE LIPID; PHOSPHOLIPID;

ALZHEIMER DISEASE; ARTICLE; CHEMISTRY; HUMAN; LIPID BILAYER; METABOLISM; PROTEIN CONFORMATION; SECRETORY VESICLE;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN; HUMANS; LIPID BILAYERS; LIPIDS; MEMBRANE LIPIDS; PHOSPHOLIPIDS; PROTEIN CONFORMATION; SECRETORY VESICLES;

EID: 77952758210     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.01.063     Document Type: Article

References (44)

1. Gellermann, G. P., T. R. Appel, ..., M. Fändrich. 2005. Raft lipids as common components of human extracellular amyloid fibrils. Proc. Natl. Acad. Sci. USA. 102:6297-6302.
2. Walsh, D. M., I. Klyubin, ..., D. J. Selkoe. 2002. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal longterm potentiation in vivo. Nature. 416:535-539.
3. Gorbenko, G. P., and P. K. J. Kinnunen. 2005. The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem. Phys. Lipids. 141:72-82.
4. Durell, S. R., H. R. Guy, ..., H. B. Pollard. 1994. Theoretical models of the ion channel structure of amyloid beta-protein. Biophys. J. 67: 2137-2145.
5. Kremer, J. J., M. M. Pallitto, ..., R. M. Murphy. 2000. Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry. 39:10309-10318.
6. Sparr, E., M. F. M. Engel, ..., J. A. Killian. 2004. Islet amyloid polypep- tide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett. 577:117-120.
7. Yang, A. J., D. Chandswangbhuvana, ..., C. G. Glabe. 1998. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abetal-42 pathogenesis. J. Neurosci. Res. 52:691-698.
8. Cecchi, C., D. Nichino, ..., A. Relini, 2009. A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells. Biochim. Biophys. Acta. 1788:2204-2216.
9. Subasinghe, S., S. Unabia, ..., D. H. Small. 2003. Cholesterol is necessary both for the toxic effect of Abeta peptides on vascular smooth muscle cells and for Abeta binding to vascular smooth muscle cell membranes. J. Neurochem. 84:471-479. (Pubitemid 36182246)
10. Devanathan, S., Z. Salamon, ..., G. Tollin. 2006. Effects of sphingomyelin, cholesterol and zinc ions on the binding, insertion and aggregation of the amyloid Abeta(1-40) peptide in solid-supported lipid bilayers. FEBS J. 273:1389-1402. (Pubitemid 44029105)
11. Ji, S. R., Y. Wu, and S. F. Sui. 2002. Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (A beta 1-40), which may potentially inhibit the fibril formation. J. Biol. Chem, 277:6273-6279.
12. Matsuzaki, K. 2007. Physicochemical interactions of amyloid-peptide with lipid bilayers. Biochim. Biophys. Acta. 1768:1935-1942. (Pubitemid 47135568)
13. Murphy, R. M. 2007. Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins. Biochim. Biophys. Acta. 1768:1923-1934.
14. Sabate, R., M. Gallardo, and J. Estelrich. 2005. Spontaneous incorporation of beta-amyloid peptide into neutral liposomes. Colloids Surf. A. Physicochem. Eng. Asp. 270:13-17. (Pubitemid 41726393)
15. Hortschansky, P., V. Schroeckh, ..., M. Fandrich. 2005. The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation. Protein Sci. 14:1753-1759. (Pubitemid 40994145)
16. Hellstrand, E., B. Boland, ..., S. Linse. 2009. An improved method for monitoring Aß aggregation produces highly reproducible kinetic data and indicate a two-phase process. ACS. Chem. Neurosci. 1:13-18.
17. Walsh, D. M., E. Thulin, ..., S. Linse. 2009. A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. FEBS J. 276:1266-1281.
18. Rouser, G., S. Fkeischer, and A. Yamamoto. 1970. Two dimensional then layer chromatographic separation, of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids. 5:494-1196
19. Biancalana, M., K. Makabe, ..., S. Koide. 2009. Molecular mechanism of thioflavin-T binding to the surface of beta-rich peptide selfassemblies. J. Mol, Biol. 385:1052-1063.
20. Cevc, G. 1993. Phospholipids Handbook. Marcel Dekker, New York, NY.
21. 2.1, Vist, M. R., and J. H. Davis. 1990. Phase-equilibria of cholesterol dipalmitoylphosphatidylcholine mixtures: H-2 nuclear magnetic resonance and differential scanning calorimetry. Biochemistry. 29:451-464.
22. Karmakar, S., V. A. Raghunathan, and S. Mayor. 2004. Phase behavior of dipalmitoyl phosphatidylcholine (DPPC)-cholesterol membranes. J. Phys. Condens. Matter. 17:1177-1182.
23. Lindblom, G., G. Oradd, and A. Filippov. 2005. Lipid lateral diffusion in bilayers with phosphatidylcholine, sphingomyelin and cholesterol-an NMR study of dynamics and lateral phase separation. Chem. Phys. Lipids. 141:179-184. (Pubitemid 43728813)
24. Larsson, K. 1994. Lipids - Molecular Organization, Physical. Functions and Technical Applications. Oily Press, Dundee, Scotland.
25. Chi, E. Y., C. Ege, ..., K. Y. Lee. 2008. Lipid membrane templates the ordering and induces the flbrillogenesis of Alzheimer's disease amyloid-beta peptide. Proteins. 72:1-24.
26. Cabaleiro-Lago, C., F. Quinlan-Pluck, ..., S. Linse. 2008. Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J. Am. Chem. Soc. 130:15437-15443.
27. Linse, S., C. Cabaleiro-Lago, ..., K. A. Dawson. 2007. Nucleation of protein fibrillation by nanoparticles. Proc. Natl. Acad. Sci. USA. 104:8691-8696.
28. Höglund, K., O. Hansson, ..., J. Wiltfang. 2008. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern, of C-terminally truncated beta-amyloid peptides. Neurodegener. Dis. 5:268-276.
29. Kuo, Y. M., M. R. Emmerling, ..., A. E. Roher. 1996. Water-soluble Abeta (N-40, N42) oligomers in nonnal and Alzheimer disease brains. J. Biol. Chem. 271:4077-4081. (Pubitemid 26070502)
30. Cabaleiro-Lago, C., F. Quinlan-Pluck, ..., S. Linse. 2010. Dual effect of amino modified polystyrene particles on amyloid β protein fibrillation. ACS Chem. Neurosci. 10.1021/cn900027u.
31. Giehm, L. O. C., G. Christiansen, ..., D. Otzen. 2010. SDS-induced fibrillation of a-synuclein: an alternative fibrillation pathway. Submitted.
32. Choucair, A., M. Chakrapani, ..., L. J. Johnston. 2007. Preferential accumulation of A beta(1-42) on gel phase domains of lipid bilayers: an AFM and fluorescence study. Biochim. Biophys. Acta. 1768: 146-154. (Pubitemid 44909080)
33. Yoda, M., T. Miura, and H. Takeuchi. 2008. Non-electrostatic binding and self-association, of amyloid beta-peptide on the surface of tightly packed phosphatidylcholine membranes. Biochem. Biophys. Res. Commun. 376:56-59.
34. D'Errico, G., G. Vitiello, ..., A. M. D'Ursi. 2008. Interaction between Alzheimer's A. beta(25-35) peptide and phospholipid bilayers: the role of cholesterol. Biochim. Biophys. Acta, 1778:2710-2716.
35. Yip, C. M., A. A. Darabie, and J. McLaurin. 2002. Abeta42-peptide assembly on lipid bilayers. J. Mol. Biol, 318:97-107.
36. Dante, S., T. Hauss, and N. A. Dencher. 2006. Cholesterol inhibits the insertion of the Alzheimer's peptide A beta(25-35) in lipid bilayers. Eur. Biophys. J. 35:523-531. (Pubitemid 44034918)
37. Kremer, J. J., D. J. Sklansky, and R. M. Murphy. 2001, Profile of changes in lipid bilayer structure caused by beta-amyloid peptide. Biochemistry. 40:8563-8571..
38. Maltseva, E., A, Kerth, ..., G. Brezesinski. 2005. Adsorption of amyloid beta (140) peptide at phospholipid monolayers. Chembiochem, 6:1817-1824.
39. Freites, J. A., S. Ali, ..., M. B. Dennin. 2004. Annexin Al interaction with a zwitterionic phospholipid monolayer: a fluorescence microscopy study. Langmuir. 20:11674-11683.
40. Haas, H., and H. Mohwald. 1989. Specific and unspecific binding of Coneanavalin A at monolayer surfaces. Thin Solid.Films. 180:101-110. (Pubitemid 20652298)
41. Blaurock, A. E., and R. C. Gamble. 1979. Small phosphatidylcholine vesicles appear to be faceted below the thermal, phase-transition. J. Membr. Biol. 50:187-204.
42. Dierksen, K., D. Typke, ..., W. Baumeister. 1995. Three-dimensional structure of lipid vesicles embedded in vitreous ice and investigated by automated electron tomography. Biophys. J. 68:1416-1422.
43. Klement, K., K. Wieligmann, ..., M. Fändrich. 2007. Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer's abeta(.1.-40) amyloid fibrils. J. Mol. Biol. 373:1321-1333. (Pubitemid 47539491)
44. Betts, V., M. A. Leissring, ..., D. M. Walsh. 2008. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21.G by neprilysin. Neurobiol. Dis. 31:442-450.